A detailed history of Entropy Technologies, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Entropy Technologies, LP holds 10,533 shares of CRL stock, worth $1.91 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
10,533
Previous 3,390 210.71%
Holding current value
$1.91 Million
Previous $919 Million 136.89%
% of portfolio
0.24%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$206.39 - $268.73 $1.47 Million - $1.92 Million
7,143 Added 210.71%
10,533 $2.18 Billion
Q1 2024

May 08, 2024

SELL
$203.52 - $273.43 $512,463 - $688,496
-2,518 Reduced 42.62%
3,390 $919 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $971,984 - $1.41 Million
5,908 New
5,908 $1.4 Billion

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.23B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.